Epzicom and Lantus drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Epzicom (abacavir sulfate; lamivudine) and Lantus (insulin glargine recombinant). Common drug interactions include pain among females and pain among males.

The phase IV clinical study analyzes what interactions people have when they take Epzicom and Lantus. It is created by eHealthMe based on reports of 69 people who take the same drugs from the FDA, and is updated regularly.

What is Epzicom?

Epzicom has active ingredients of abacavir sulfate; lamivudine. It is often used in hiv infection. eHealthMe is studying from 4,937 Epzicom users. Check the latest studies of Epzicom.

What is Lantus?

Lantus has active ingredients of insulin glargine recombinant. It is often used in diabetes. eHealthMe is studying from 191,782 Lantus users. Check the latest studies of Lantus.



On Jul, 25, 2026

69 people who take Epzicom and Lantus together, and have interactions are studied.

Epzicom and Lantus drug interactions.

What are the common drug interactions of Epzicom and Lantus, by gender? *:

female:

  1. Pain
  2. Renal failure (kidney dysfunction)
  3. Abdominal pain
  4. Anal haemorrhage
  5. Asthenia (weakness)
  6. Back pain
  7. Blood pressure increased
  8. Bone density decreased
  9. Chest pain
  10. Chills (felling of cold)

male:

  1. Pain
  2. Emotional distress
  3. Hypertension (high blood pressure)
  4. Dizziness
  5. Fatigue (feeling of tiredness)
  6. Osteoporosis (bones weak and more likely to break)
  7. Hyperkalaemia (damage to or disease of the kidney)
  8. Osteopenia (a condition where bone mineral density is lower than normal)
  9. Asthenia (weakness)
  10. Blood glucose increased

What are the common drug interactions of Epzicom and Lantus, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Anaemia (lack of blood)
  2. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  3. Anxiety
  4. Blood creatinine increased
  5. Chronic kidney disease
  6. Emotional distress
  7. Fanconi syndrome acquired (self developed genetic disease of kidney damage due to defective transport system)
  8. Hyperkalaemia (damage to or disease of the kidney)
  9. Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
  10. Pain

20-29:

  1. Foot fracture
  2. Hyperkalaemia (damage to or disease of the kidney)
  3. Anaemia of chronic disease
  4. Bone density decreased
  5. Chronic kidney disease
  6. Emotional distress
  7. Hypertension (high blood pressure)
  8. Multiple fractures
  9. Nephropathy (damage to or disease of a kidney)
  10. Osteopenia (a condition where bone mineral density is lower than normal)

30-39:

n/a

40-49:

  1. Pain
  2. Renal failure (kidney dysfunction)
  3. Dizziness
  4. Vision blurred
  5. Arthritis (form of joint disorder that involves inflammation of one or more joints)
  6. Asthenia (weakness)
  7. Asthma
  8. Blindness
  9. Blood glucose increased
  10. Diabetes mellitus inadequate control

50-59:

  1. Drug ineffective
  2. Dysgeusia (disorder of the sense of taste)
  3. Epistaxis (bleed from the nose)
  4. Erectile dysfunction
  5. Fall
  6. Fatigue (feeling of tiredness)
  7. Haemorrhagic transformation stroke (haemorrhages develop inside areas of ischemia)
  8. Hypercholesterolaemia (high levels of cholesterol in the blood)
  9. Hypotension (abnormally low blood pressure)
  10. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development)

60+:

  1. Depression
  2. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  3. Abdominal symptom
  4. Cerebral artery stenosis (hardening of brain blood vessels)
  5. Dementia (madness)
  6. Depressed level of consciousness
  7. Eating disorder
  8. Femur fracture
  9. Haemarthrosis (haemarthrosis is where blood is able to enter the joint capsule)
  10. Haemophilic arthropathy (permanent joint disease)

What are the existing conditions these people have? *

  1. High Blood Pressure: 12 people, 17.39%
  2. Panic Disorder: 6 people, 8.70%
  3. Hepatitis C: 6 people, 8.70%
  4. Epididymitis (pain in the scrotum or testicle): 6 people, 8.70%
  5. Pain: 5 people, 7.25%
  6. High Blood Cholesterol: 5 people, 7.25%
  7. Abdominal Pain Upper: 5 people, 7.25%

* Approximation only. Some reports may have incomplete information.

Do you take Epzicom and Lantus?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Epzicom and Lantus:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Epzicom:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Lantus:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Epzicom and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Lantus and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on abacavir sulfate; lamivudine and insulin glargine recombinant (the active ingredients of Epzicom and Lantus, respectively), and Epzicom and Lantus (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: